Related Experiment Video
Updated: Jul 7, 2026
08:19
Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
Published on: November 17, 2015
Potential of solid lipid nanoparticles in brain targeting
Indu Pal Kaur1, Rohit Bhandari, Swati Bhandari
1University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160 014, India.
Summary
Nanoparticles, particularly solid lipid nanoparticles (SLNs), offer a promising solution for delivering drugs across the blood-brain barrier. Their lipidic nature and small size facilitate brain uptake, overcoming delivery challenges.
Area of Science:
- Neuroscience
- Pharmacology
- Materials Science
Background:
- The brain's blood-brain barrier (BBB) presents significant obstacles to drug delivery due to tight junctions and efflux transporters.
- Many promising drug candidates fail due to insufficient brain penetration and concentration.
- Current invasive methods for brain drug delivery are patient-unfriendly and carry risks.
Purpose of the Study:
- To explore nanoparticles, specifically solid lipid nanoparticles (SLNs), as a novel drug delivery system for enhanced brain targeting.
- To review strategies for bypassing the blood-brain barrier and the characterization of SLNs.
Main Methods:
- Discussion of barriers to central nervous system (CNS) drug delivery.
- Review of strategies to overcome the blood-brain barrier.
- Exploration of nanoparticle characteristics, including SLNs, for brain delivery.
Main Results:
- SLNs are readily taken up by the brain due to their lipidic nature.
- SLNs offer advantages such as biodegradability, prolonged circulation time, and scalability.
- Nanoparticles represent a less invasive and potentially more effective approach to brain drug delivery.
Conclusions:
- SLNs are a viable and promising platform for targeted brain drug delivery.
- Further research into SLN mechanisms, optimization, and assessment is warranted.
- Nanoparticle-based strategies hold significant potential for improving therapeutic outcomes in neurological disorders.
